Sermorelin (Growth Hormone Releasing Hormone Analog) – GRF 1-29

Product Overview

Sermorelin is a highly studied, synthetic 29-amino-acid peptide that corresponds to the active amino-terminal fragment of endogenous human Growth Hormone Releasing Hormone (GHRH). Unlike exogenous growth hormone administration that can suppress natural pituitary function, Sermorelin is engineered to act as a powerful secretagogue that encourages the body's own production of GH. It is a premier compound utilized in advanced endocrinology and anti-aging research to investigate the restoration of physiological growth hormone pulsatility and the preservation of vital hormonal feedback loops.

Technical Specifications

• Molecular Formula: C149H246N44O42S

• Sequence Profile: Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 (Represents the first 29 amino acids of the 44-amino-acid natural GHRH molecule, retaining full biological activity)

Mechanism of Action

Sermorelin exerts its potent neuroendocrine effects by mimicking natural physiological signaling pathways:

• GHRH Receptor Agonism: Binds with high affinity to GHRH receptors on somatotroph cells in the anterior pituitary gland, activating the Gαs/adenylate cyclase/cAMP/PKA cascade that drives the synthesis and secretion of growth hormone.

• Pulsatile Physiological Release: Due to its rapid clearance profile, it effectively mimics the natural nocturnal bursts of GHRH from the hypothalamus. This produces discrete GH secretory episodes (pulses) rather than unnatural, constant hormonal elevations.

• Feedback Loop Preservation: Because it stimulates endogenous production, the natural hypothalamic-pituitary negative feedback regulatory system remains completely intact. As IGF-1 levels rise, they signal the hypothalamus to naturally reduce GHRH output, preventing dangerous GH excess and receptor down-regulation.

• Pituitary Trophic Function: "Exercises" the pituitary gland, potentially preserving or restoring somatotroph responsiveness and functional capacity in aging models.

Primary Research Applications

Sermorelin is a critical compound for in vitro and animal model studies investigating:

• Endogenous Growth Hormone Deficiency and Somatotroph Responsiveness

• Age-Related Hormonal Decline and Pituitary Reserve Restoration

• IGF-1 Optimization and Body Composition (Lean muscle mass and visceral adiposity)

• Sleep Architecture (Enhancement of Stage 3 slow-wave/deep sleep)

• Peptide Synergism (Stacking with GHRPs to overcome negative feedback inhibition)

Storage & Handling

For optimal long-term stability and structural integrity, store lyophilized powder securely at -4°F (-20°C). Reconstituted solutions should be kept refrigerated at 36°F to 46°F (2°C to 8°C) and utilized promptly according to laboratory protocols.

⚠️ Important Disclaimer for Carbon Nova Labs Customers: All information provided is for educational and reference purposes only. Sermorelin is sold strictly for laboratory research use only. This compound is not approved by the FDA for human consumption, therapeutic use, or clinical application. Ensure compliance with all institutional safety protocols and consult qualified professionals before conducting research.